Topical Treatments for Bacterial Conjunctivitis
For mild bacterial conjunctivitis, use any broad-spectrum topical antibiotic for 5-7 days, selecting the most convenient or least expensive option, as no specific antibiotic has proven superiority. 1
Treatment Algorithm by Severity
Mild Bacterial Conjunctivitis
The condition is self-limited in immunocompetent adults and typically resolves spontaneously. However, topical antibiotics provide meaningful benefits 1:
- Accelerate clinical resolution by days 2-5 of treatment
- Reduce transmissibility and allow earlier return to school/work
- Shorten symptom duration compared to placebo 2
Antibiotic selection: Choose empirically based on convenience and cost. Options include:
- Fluoroquinolones (moxifloxacin, besifloxacin, lomefloxacin)
- Polymyxin-bacitracin
- Chloramphenicol
- Azithromycin
Duration: 5-7 days, applied 3-4 times daily 1
Alternative when antibiotics unavailable: Povidone-iodine 1.25% ophthalmic solution is equally effective 1
Moderate to Severe Bacterial Conjunctivitis
Characterized by copious purulent discharge, pain, and marked inflammation 1:
- Obtain conjunctival cultures and Gram stain before treatment, especially if gonococcal infection suspected
- Consider MRSA coverage given increasing prevalence, particularly in nursing home residents
- Use culture-guided therapy when available
- Consider compounded vancomycin for MRSA or resistant organisms 1
Critical pitfall: Infants in neonatal intensive care with low birth weight/gestational age frequently harbor gentamicin-resistant gram-negative organisms—avoid gentamicin monotherapy 1
Special Situations Requiring Systemic Therapy
Gonococcal conjunctivitis:
- Systemic antibiotics are mandatory—topical therapy alone is insufficient 1
- Add saline lavage for comfort
- Add topical antibiotics only if corneal involvement present
- Daily follow-up required until resolution
- Screen and treat sexual contacts; consider sexual abuse in children
Chlamydial conjunctivitis:
- Systemic therapy required (>50% of infants have infection at other sites: nasopharynx, genital tract, lungs) 1
- No evidence supports adding topical therapy to systemic treatment
- Treatment failure rate up to 19%—re-evaluate after treatment
- Treat sexual contacts simultaneously; consider sexual abuse in children
Clinical Outcomes Data
Spontaneous resolution occurs in 55.5% of placebo-treated patients by days 4-9, versus 68.2% with antibiotics 2. While the absolute benefit is modest (26% improvement in clinical cure), antibiotics reduce:
- Persistent clinical infection by 27% (RR 0.73) 2
- Treatment incompletion by 36% (RR 0.64) 2
- Time to bacterial eradication: 71% by day 3-5 with antibiotics versus 19% with placebo 3
Follow-Up Recommendations
- Return in 3-4 days if no improvement for non-gonococcal bacterial conjunctivitis 1
- Daily visits for gonococcal conjunctivitis until resolution 1
- At each visit: interval history, visual acuity, slit-lamp examination
Safety Profile
No serious systemic side effects reported with topical antibiotics 2. Fluoroquinolones have lower rates of ocular side effects (RR 0.70) compared to non-fluoroquinolones (RR 4.05), though evidence certainty is very low 2.